Results of the first phase 3 trial in this field were announced.
Ophthalmic Product Development Insights
Early detection may allow treatment, and possibly reversal. Part 2 of a two-part series.
When it comes to your site’s qualifications, you must be forthcoming with study sponsors.
A look at the latest research from multiple corners of ophthalmology, from gene therapy to dry eye.
Numerous approaches to treatment of dry AMD are under development.
Explaining both the demands and potential rewards of a clinical trial can make patients more
likely to participate fully in the protocol.
Exposure to certain wavelengths of blue light carries potential blinding effects and a
link to AMD.
Many efforts are under way to improve drug delivery to the back of the eye.
Technological integration seeps into the clinical research space.